Study summary
KC1036 shrank about 3 in 10 tumors in a small group
30%of tumors shrank, 8 of 27 people
What was tested
KC1036, a pill that blocks several growth signals, in people with advanced squamous esophageal cancer. No comparison group.
What they found
- 8 of 27 tumors shrank, 15 held steady and 4 grew.
- The report we found did not clearly identify which study the figures came from.
What it means
Enough to start a 490-person phase 3 against chemotherapy as a third treatment, due to finish December 2026.
Last reviewed 2026-11-14 by the Find a Trial editorial team.
Information on this page is for educational purposes and is not medical advice.
Always consult qualified healthcare professionals about clinical trial participation.